Practice Management News

The European Union Court of Justice has ruled that illnesses can be attributed to vaccines during litigation without scientific proof.

Experts from four leading nonprofits in the addiction field have determined that existing legislation does not adequately protect insurance coverage of substance abuse disorders, according to a press release.

In introducing the FDA’s Drug Competition Action Plan, the commissioner announced his intent to assess ways FDA rules may be misused to create obstacles against generic drug access and competition; the organization plans to hold a meeting on July 18, 2017, to solicit input from the public.

CMS recently issued a proposed rule to update the Quality Payment Program as required by the Medicare Access and CHIP Reauthorization Act of 2015 to simplify reporting requirements, ensure fiscal sustainability and high-quality care within Medicare, and offer support for clinicians in 2018, according to a press release.

Medical license application questions are still not treating mental and physical illness the same, and this could be impacting a physician’s decision to seek treatment for mental disorders, according to findings recently published in Family Medicine.

At the recent International Liver Congress, the European Association for the Study of the Liver released five different guidelines for the management of liver disease. I encourage you to read our summaries, briefly here and more in-depth online, and consider how these may help you in your daily practice.

Days before an expected vote, HHS Secretary Tom Price, MD, said he has not seen the U.S. Senate bill to overhaul the nation’s health care system.

On the last day of voting at its 2017 annual meeting, the AMA approved new policies safeguarding insurance across state lines, protecting funding for 911 services and ensuring that international physicians and medical students are able to practice medicine and obtain training in the United States, according to two separate press releases.

In response to the recent spike of many prescription drug prices, the AMA adopted several policies to provide patients with more information about the drugs that they are prescribed and a rationale for price increases at its 2017 annual meeting, according to a press release.

On the final day of its annual meeting, AMA delegates adopted a new policy designed to improve medical student and physician access to mental health care, according to a press release.